BCL2 and diffuse large B-cell lymphoma: The t(14;18)(q32;q21) translocation characterizes approximately 85% of FL and 20% of diffuse large B-cell lymphoma (DLBCL) and results in constitutive overexpression of the anti-apoptotic protein BCL-2 [14, 15].